Protecting Your Retina: Managing Edema and Retinopathy Risks
At a Glance
After cataract surgery, people with diabetes have a higher risk of retinal swelling and diabetic retinopathy progression, especially if disease is already present. Anti-inflammatory drops, selected injections, and scheduled retinal scans help prevent or detect complications early.
While cataract surgery is generally safe, having diabetes means your retina—the light-sensitive tissue at the back of the eye—requires extra protection. The stress of surgery, though minor, can trigger inflammation that a diabetic eye may struggle to clear [1]. The two primary risks are diabetic macular edema (DME) (swelling in the center of the retina) and the progression of diabetic retinopathy (DR) (damage to the blood vessels) [2][1].
The Risk of Postoperative Swelling (DME)
In the general population, some minor swelling after cataract surgery is common and usually resolves on its own. However, in people with diabetes, this swelling can be more severe and persistent [1].
Your risk for developing DME that requires treatment often becomes evident in the first 4-8 weeks, while the risk for treatment-requiring DME continues to peak between 3 and 6 months after surgery [1]. The likelihood of this happening depends heavily on the health of your retina before you enter the operating room.
Risk by Retinal Status
A large database study found that the risk of needing treatment for macular edema in the first year after surgery follows a clear pattern based on your preoperative stage in a specific database population followed for one year. (Note: These are population estimates, not personal probabilities, and pre-existing DME makes risk much higher) [1]:
| Preoperative Retinal Status | Risk of Treatment-Requiring DME |
|---|---|
| No Retinopathy | ~1.0% |
| Mild NPDR (Non-Proliferative) | ~5.4% |
| Moderate NPDR | ~10.0% |
| Severe NPDR | ~13.1% |
Note: PDR (Proliferative Diabetic Retinopathy) showed a lower rate (~4.9%) in some studies, likely because these patients often already have intensive retinal treatments (like lasers or injections) in place [1].
Progression of Retinopathy
Surgery can sometimes be associated with a progression of underlying diabetic eye disease. Research indicates that cataract surgery is associated with an increased risk of your retinopathy progressing to a more advanced stage [2]. Some observational studies suggest the risk of retinopathy worsening can be up to 3 times higher in operated eyes compared to non-operated eyes in the same patient, but the exact magnitude depends heavily on your baseline health and treatment [3].
Prophylaxis: The “Double-Drop” Strategy
To lower these risks, your doctor will likely use a more aggressive drop regimen than a non-diabetic patient would receive.
- Steroid + NSAID: Practice varies, but many doctors use both a topical corticosteroid and a Non-Steroidal Anti-Inflammatory Drug (NSAID) drop [4].
- The Benefit: Combining these drops has been shown to reduce the relative risk of macular edema by 75.8% in one study compared to using steroids alone [4]. These drops work together to block different inflammatory pathways that lead to swelling, but drops have their own side effects and must be monitored [5].
Managing Active Disease: Injections and Implants
If you already have active swelling (DME) or severe retinopathy, “dropping” the eye may not be enough. In these cases, your surgeon may recommend perioperative injections—medications placed inside the eye near the time of surgery [6]. These are NOT routine prophylaxis for every diabetic patient, but are selected for active DME or high-risk eyes.
- Anti-VEGF Injections: Medications like bevacizumab or ranibizumab can help reduce macular thickness and may prevent your retinopathy from worsening in the months following surgery [6][7].
- Steroid Implants: For some patients, a slow-release steroid implant (like dexamethasone) may be used. These can offer superior “anatomical” outcomes—meaning the retina stays flatter—but they carry a higher risk of increasing eye pressure [8].
- Pre-Surgery Stabilization: If you have active fluid in your retina, it is often best to have one or more injections before the cataract surgery to stabilize the tissue [9].
Long-Term Monitoring
Because the risk of swelling peaks months after the surgery, your care does not end when your vision first clears up. You should expect a retinal check-up (often including an OCT scan) at the 1-month and 3-to-6-month marks to ensure no hidden swelling is developing [2][1].
If your vision becomes distorted or “wavy” at any point after surgery, contact your eye doctor immediately, as this is a primary sign of fluid buildup in the macula.
Common questions in this guide
How likely is macular edema after cataract surgery if I have diabetes?
When is retinal swelling most likely to appear after surgery?
Why might I need both steroid and NSAID eye drops?
Would I need an eye injection or steroid implant before cataract surgery?
Can cataract surgery make diabetic retinopathy worse?
What follow-up and warning signs should I expect after surgery?
Appointments are short. Make every minute count.
Specialist visits move fast. Let us help you prep so your time goes to what matters.
Preventing swelling
Which eye drops might my doctor use to lower swelling risk around surgery?
Injection options
Could injections near the time of surgery be an option for me, and when would they be used?
Follow-up retinal checks
When would I need a retinal check-up with an OCT scan after surgery?
Get notified when new evidence is published on diabetic cataract.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (9)
- 1
The UK Diabetic Retinopathy Electronic Medical Record (UK DR EMR) Users Group, Report 2: real-world data for the impact of cataract surgery on diabetic macular oedema.
Denniston AK, Chakravarthy U, Zhu H, et al.
The British journal of ophthalmology 2017; (101(12)):1673-1678 doi:10.1136/bjophthalmol-2016-309838.
PMID: 28487377 - 2
Incidence and Progression of Diabetic Retinopathy After Cataract Surgery: A Systematic Review and Meta-Analysis.
Lee SH, Tseng BY, Wu MC, et al.
American journal of ophthalmology 2025; (269()):105-115 doi:10.1016/j.ajo.2024.08.017.
PMID: 39179126 - 3
Association between cataract surgery and diabetic retinopathy incidence and progression: an 11-year population-based retrospective cohort study.
Chang YC, Wang JH, Chen WT, Chiu CJ
BMJ open 2026; (16(9)):e120170 doi:10.1136/bmjopen-2026-120170.
PMID: 42692501 - 4
Prevention of macular edema in patients with diabetes after cataract surgery.
Laursen SB, Erichsen JH, Holm LM, Kessel L
Journal of cataract and refractive surgery 2019; (45(6)):854-869 doi:10.1016/j.jcrs.2019.04.025.
PMID: 31146934 - 5
Management of macular oedema in diabetic patients undergoing cataract surgery.
Boscia F, Giancipoli E, D'Amico Ricci G, Pinna A
Current opinion in ophthalmology 2017; (28(1)):23-28 doi:10.1097/ICU.0000000000000328.
PMID: 27661663 - 6
A Systematic Review and Meta-Analysis of Clinical Outcomes of Intravitreal Anti-VEGF Agent Treatment Immediately after Cataract Surgery for Patients with Diabetic Retinopathy.
Zhao LQ, Cheng JW
Journal of ophthalmology 2019; (2019()):2648267 doi:10.1155/2019/2648267.
PMID: 31143469 - 7
Prophylactic interventions for preventing macular edema after cataract surgery in patients with diabetes: A Bayesian network meta-analysis of randomized controlled trials.
Zhang R, Dong L, Yang Q, et al.
EClinicalMedicine 2022; (49()):101463 doi:10.1016/j.eclinm.2022.101463.
PMID: 35747191 - 8
A meta-analysis of the effect of a dexamethasone intravitreal implant versus intravitreal anti-vascular endothelial growth factor treatment for diabetic macular edema.
He Y, Ren XJ, Hu BJ, et al.
BMC ophthalmology 2018; (18(1)):121 doi:10.1186/s12886-018-0779-1.
PMID: 29784048 - 9
Optimizing treatment for diabetic macular edema during cataract surgery.
Chan LKY, Lin SS, Chan F, Ng DS
Frontiers in endocrinology 2023; (14()):1106706 doi:10.3389/fendo.2023.1106706.
PMID: 36761187
This page explains retinal risks and monitoring after cataract surgery in people with diabetes for informational purposes only; it does not constitute medical advice. Your ophthalmologist or retina specialist should determine whether you need drops, injections, laser treatment, and follow-up based on your eye findings.